BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3143869)

  • 1. [Correlation of skin tests and the production of gamma-interferon in leprosy patients].
    Suso L; Nogueira N; Vieira LM; Figueiredo AA; Porto JA; Sarno EN
    Med Cutan Ibero Lat Am; 1988; 16(3):193-6. PubMed ID: 3143869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
    Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
    Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single cell assay for the study of gamma-interferon formation in leprosy patients.
    Lindh J; Anderson U; Britton S; De Ley M
    Clin Exp Immunol; 1987 Jan; 67(1):51-4. PubMed ID: 3040308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma responses to candidate leprosy skin-test reagents detect exposure to leprosy in an endemic population.
    Manandhar R; LeMaster JW; Butlin CR; Brennan PJ; Roche PW
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):40-8. PubMed ID: 10834068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
    Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
    Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunobiology of leprosy.
    Kaplan G; Cohn ZA
    Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
    Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of cytokine response against panel of purified Mycobacterium leprae antigens by using whole blood assay in subjects residing in a resettlement village of cured leprosy patients.
    Kamble RR; Shinde VS; Madhale SP; Jadhav RS
    Indian J Lepr; 2010; 82(1):23-31. PubMed ID: 21229844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae.
    Misra N; Murtaza A; Walker B; Narayan NP; Misra RS; Ramesh V; Singh S; Colston MJ; Nath I
    Immunology; 1995 Sep; 86(1):97-103. PubMed ID: 7590888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
    Bapat CV; Modak MS; DeSouza NG; Chulawalla RG
    Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
    Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
    Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the Mitsuda reaction to Mycobacterium leprae can be mediated by lymphocytes responsive to Mycobacterium tuberculosis.
    Roberts PP; Dockrell HM; McAdam KP
    Clin Exp Immunol; 1988 Jun; 72(3):390-3. PubMed ID: 2458870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
    Mohanty KK; Joshi B; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.